{"recordsFiltered":50704,"recordsTotal":50704,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=48600","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=48000","results":[{"registry_id":"NCT05968898","publication_url":"https://clinicaltrials.gov/study/NCT05968898","title":"Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules","has_exemption":false,"start_date":"2024-01-09","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06213649","publication_url":"https://clinicaltrials.gov/study/NCT06213649","title":"Parasitic Ulcer Treatment Trial","has_exemption":false,"start_date":"2024-07-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Jeremy Keenan, MD, MPH","sponsor_slug":"jeremy-keenan-md-mph","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06009159","publication_url":"https://clinicaltrials.gov/study/NCT06009159","title":"Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients","has_exemption":false,"start_date":"2024-07-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06328777","publication_url":"https://clinicaltrials.gov/study/NCT06328777","title":"A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Systemic Sclerosis","has_exemption":false,"start_date":"2024-07-02","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Cabaletta Bio","sponsor_slug":"cabaletta-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07823036","publication_url":"https://clinicaltrials.gov/study/NCT07823036","title":"Assessing Pulmonary Changes in Hematopoietic Stem-Cell Transplantation Patients and Patients With Rare-Lung Diseases Using Hyperpolarized Xe MR Lung Imaging","has_exemption":false,"start_date":"2024-07-24","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06536413","publication_url":"https://clinicaltrials.gov/study/NCT06536413","title":"Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib","has_exemption":false,"start_date":"2024-07-29","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06171685","publication_url":"https://clinicaltrials.gov/study/NCT06171685","title":"MMRC Horizon One: A Phase II Randomized Adaptive Platform Trial Evaluating Novel Therapies in Relapsed or Refractory Multiple Myeloma (MMRC-099)","has_exemption":false,"start_date":"2024-11-17","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Multiple Myeloma Research Consortium","sponsor_slug":"multiple-myeloma-research-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06734351","publication_url":"https://clinicaltrials.gov/study/NCT06734351","title":"A Multicenter, Evaluator and Subject-blinded, Randomized, Comparator-controlled, Parallel-design Study to Evaluate the Safety and Effectiveness of NOA VOLUME Compared to JUVÉDERM® VOLUMA® XC for Improvement of Mid-face Volume","has_exemption":false,"start_date":"2024-12-16","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712823","publication_url":"https://clinicaltrials.gov/study/NCT06712823","title":"An Open-label, Long-term Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia (CALM2-CAH)","has_exemption":false,"start_date":"2025-02-25","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06846463","publication_url":"https://clinicaltrials.gov/study/NCT06846463","title":"Phase 2 Trial Utilizing Zanubrutinib in Patients With Diffuse Large B-cell Lymphoma and MYD88 L265P Mutations, CD79B Mutations, NOTCH1 Truncation or Who Are CD5+ by IHC.","has_exemption":false,"start_date":"2025-05-27","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07026279","publication_url":"https://clinicaltrials.gov/study/NCT07026279","title":"A Phase 1b/2a, Multicenter, Open Label Study of the Safety, Efficacy and Pharmacokinetics of Narmafotinib in Combination With Modified FOLFIRINOX in Pancreatic Cancer Patients","has_exemption":false,"start_date":"2025-08-18","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Amplia Therapeutics Limited","sponsor_slug":"amplia-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140679","publication_url":"https://clinicaltrials.gov/study/NCT07140679","title":"A Phase II Trial of Adjuvant Toripalimab in High Risk Localized Colon Cancer With Mismatch Repair Deficiency","has_exemption":false,"start_date":"2025-09-19","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06274112","publication_url":"https://clinicaltrials.gov/study/NCT06274112","title":"Personalized Neuromodulation Targeting Dysregulated Motivational Responses Underlying Social Avoidance Behavior","has_exemption":false,"start_date":"2025-09-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Auburn University","sponsor_slug":"auburn-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07201207","publication_url":"https://clinicaltrials.gov/study/NCT07201207","title":"Single-center, Randomized, Controlled, Double Blinded, 24-month Trial to Compare Robotic-assisted (MAKO) and Manual Total Knee Arthroplasty for Primary Osteoarthritis With 10 Year Follow-up for Complications","has_exemption":false,"start_date":"2025-09-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Satakunta Central Hospital","sponsor_slug":"satakunta-central-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06325202","publication_url":"https://clinicaltrials.gov/study/NCT06325202","title":"Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC)","has_exemption":false,"start_date":"2025-10-03","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174583","publication_url":"https://clinicaltrials.gov/study/NCT07174583","title":"A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE849 in Patients With DLL3-Expressing Tumors Including Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-10-14","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"IDEAYA Biosciences","sponsor_slug":"ideaya-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07247084","publication_url":"https://clinicaltrials.gov/study/NCT07247084","title":"A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting","has_exemption":false,"start_date":"2025-11-24","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221253","publication_url":"https://clinicaltrials.gov/study/NCT07221253","title":"Phase III, Randomized, Open-label, Global, Multicenter Study of Rilvegostomig or Durvalumab in Combination With Chemotherapy as a First-line Treatment for Patients With Advanced Biliary Tract Cancer (ARTEMIDE-Biliary02)","has_exemption":false,"start_date":"2025-12-04","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227818","publication_url":"https://clinicaltrials.gov/study/NCT07227818","title":"A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia","has_exemption":false,"start_date":"2025-12-16","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06994442","publication_url":"https://clinicaltrials.gov/study/NCT06994442","title":"Optimizing Pain Treatment in Children On Mechanical Ventilation","has_exemption":false,"start_date":"2025-12-29","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07157033","publication_url":"https://clinicaltrials.gov/study/NCT07157033","title":"A Phase 1/2a, Open Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of XER-001 (Amifostibe for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment of Locally-Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-01-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Xerient Pharma","sponsor_slug":"xerient-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287449","publication_url":"https://clinicaltrials.gov/study/NCT07287449","title":"A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level","has_exemption":false,"start_date":"2026-01-05","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Dymicron","sponsor_slug":"dymicron","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07191327","publication_url":"https://clinicaltrials.gov/study/NCT07191327","title":"Testing Personalized High Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy","has_exemption":false,"start_date":"2026-01-28","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665074","publication_url":"https://clinicaltrials.gov/study/NCT06665074","title":"Inflammatory Challenge in Human Aggression.","has_exemption":false,"start_date":"2026-02-16","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07055581","publication_url":"https://clinicaltrials.gov/study/NCT07055581","title":"A Phase II Study of Durvalumab Combined With EP Prior to Chemoradiotherapy and Followed by Durvalumab as Consolidation for Patients With Limited-stage Small-cell Lung Cancer (CONCUR Study)","has_exemption":false,"start_date":"2026-02-24","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Qian Chu","sponsor_slug":"qian-chu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285655","publication_url":"https://clinicaltrials.gov/study/NCT07285655","title":"A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)","has_exemption":false,"start_date":"2026-04-23","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Liquidia Technologies, Inc.","sponsor_slug":"liquidia-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07488676","publication_url":"https://clinicaltrials.gov/study/NCT07488676","title":"A Phase 1b/2 Open-label Study to Assess the Safety and Efficacy of ASP546C in Participants With CLDN18.2-expressing Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma, Pancreatic Adenocarcinoma or Other Solid Tumor Types","has_exemption":false,"start_date":"2026-05-04","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07323524","publication_url":"https://clinicaltrials.gov/study/NCT07323524","title":"Sodium-Glucose Co-Transporter-2 Inhibitors in Lupus Nephritis","has_exemption":false,"start_date":"2026-05-19","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277309","publication_url":"https://clinicaltrials.gov/study/NCT07277309","title":"Promoting Recovery After Brain Injury Using Focused Ultrasound","has_exemption":false,"start_date":"2026-05-26","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07563881","publication_url":"https://clinicaltrials.gov/study/NCT07563881","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures","has_exemption":false,"start_date":"2026-06-05","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Rapport Therapeutics Inc.","sponsor_slug":"rapport-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293546","publication_url":"https://clinicaltrials.gov/study/NCT07293546","title":"An Open-Label First-in-Human Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of FRF-001, an AAV-9 Gene Therapy Administered by Intracerebroventricular Injection in Participants With FOXG1 Syndrome","has_exemption":false,"start_date":"2026-07-20","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"FOXG1 Research Foundation","sponsor_slug":"foxg1-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07725497","publication_url":"https://clinicaltrials.gov/study/NCT07725497","title":"A Multicenter Phase 2 Study of Luspatercept in Patients With Anemia Due to Chronic Kidney Disease","has_exemption":false,"start_date":"2026-07-20","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07688213","publication_url":"https://clinicaltrials.gov/study/NCT07688213","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 48-week SAR448851 Treatment Followed by Open-label Extension in Participants With Early Alzheimer's Disease","has_exemption":false,"start_date":"2026-07-28","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07449975","publication_url":"https://clinicaltrials.gov/study/NCT07449975","title":"A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Umbilical CORD-Based Skin Substitutes and Standard of Care Versus Standard of Care Alone in the Treatment of Hard-to-Heal Diabetic Foot Ulcers","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"StimLabs","sponsor_slug":"stimlabs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07449988","publication_url":"https://clinicaltrials.gov/study/NCT07449988","title":"A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Umbilical CORD-Based Skin Substitutes and Standard of Care Versus Standard of Care Alone in the Treatment of Hard-to-Heal Venous Leg Ulcers","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"StimLabs","sponsor_slug":"stimlabs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07593261","publication_url":"https://clinicaltrials.gov/study/NCT07593261","title":"MARACAS: A Phase II Trial of MRI-guided Adaptive Stereotactic RAdiotherapy in oligometastatiC Patients With Peritoneal Spread.","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","sponsor_slug":"fondazione-policlinico-universitario-agostino-gemelli-irccs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07671365","publication_url":"https://clinicaltrials.gov/study/NCT07671365","title":"Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Methodist Healthcare System of San Antonio","sponsor_slug":"methodist-healthcare-system-of-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07733557","publication_url":"https://clinicaltrials.gov/study/NCT07733557","title":"Concordance of HPV Detection Using Self-Collected Menstrual Blood","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Samantha Batman","sponsor_slug":"samantha-batman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919835","publication_url":"https://clinicaltrials.gov/study/NCT06919835","title":"CiLostAzol for pReventIon of Recurrent sTroke in Africa","has_exemption":false,"start_date":"2026-08-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Northern California Institute of Research and Education","sponsor_slug":"northern-california-institute-of-research-and-education","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07763015","publication_url":"https://clinicaltrials.gov/study/NCT07763015","title":"A Phase 2a, Multicenter, Open-label, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Resmetirom in Pediatric Subjects Ages 6-17 Years With MASH With Fibrosis Stage F1-F3","has_exemption":false,"start_date":"2026-08-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Madrigal Pharmaceuticals, Inc.","sponsor_slug":"madrigal-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07391774","publication_url":"https://clinicaltrials.gov/study/NCT07391774","title":"A Phase III Trial of Rx Therapy Guided by Genomic Risk Assessment For High Anatomic Stage ER-pos/HER2-neg Breast Cancer With RS Less Than or Equal to 25 (RxFINE-Low)","has_exemption":false,"start_date":"2026-08-10","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07702032","publication_url":"https://clinicaltrials.gov/study/NCT07702032","title":"A Randomized, Open-label, Phase 3 Trial of Petosemtamab in Combination With mFOLFOX6 or FOLFIRI Versus Cetuximab in Combination With mFOLFOX6 or FOLFIRI as First-line Treatment for Participants With RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer","has_exemption":false,"start_date":"2026-08-11","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07021989","publication_url":"https://clinicaltrials.gov/study/NCT07021989","title":"Pembrolizumab and GVD With ctDNA-guided Consolidation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium","has_exemption":false,"start_date":"2026-08-18","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Michael Spinner, MD","sponsor_slug":"michael-spinner-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07773753","publication_url":"https://clinicaltrials.gov/study/NCT07773753","title":"Validation of the Vision Trainer Clinical Decision-Support Software:A Randomized Comparison of Software-Guided Subjective Refraction(JCC and Non-JCC Algorithms) Against Unassisted Manual Refraction","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07804056","publication_url":"https://clinicaltrials.gov/study/NCT07804056","title":"A Randomized Phase III Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2026-09-17","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Hamlet Pharma AB","sponsor_slug":"hamlet-pharma-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07594119","publication_url":"https://clinicaltrials.gov/study/NCT07594119","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Rapport Therapeutics Inc.","sponsor_slug":"rapport-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07784829","publication_url":"https://clinicaltrials.gov/study/NCT07784829","title":"Urine Resazurin Reduction Ratio and Phenotypic Antibiotic Susceptibility Testing: A Rapid Diagnostic Tool for Urinary Tract Infection and Lower Urinary Tract Dysfunction Using a Catheter","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07807969","publication_url":"https://clinicaltrials.gov/study/NCT07807969","title":"A Multicenter, Open-Label Extension Study of the Long-Term Safety of Vonaprument (ANX007) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Annexon, Inc.","sponsor_slug":"annexon-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07729852","publication_url":"https://clinicaltrials.gov/study/NCT07729852","title":"Open-Label Extension Study to Provide Access to ATH434 in Patients With Multiple System Atrophy","has_exemption":false,"start_date":"2026-10-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Alterity Therapeutics","sponsor_slug":"alterity-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526896","publication_url":"https://clinicaltrials.gov/study/NCT07526896","title":"Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing","has_exemption":false,"start_date":"2026-10-13","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiac Rhythm and Heart Failure","sponsor_slug":"medtronic-cardiac-rhythm-and-heart-failure","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07778836","publication_url":"https://clinicaltrials.gov/study/NCT07778836","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia","has_exemption":false,"start_date":"2026-10-26","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Larimar Therapeutics, Inc.","sponsor_slug":"larimar-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07584369","publication_url":"https://clinicaltrials.gov/study/NCT07584369","title":"Short-term Effects of Methamphetamine on Residual Latent HIV Disease (EMRLHD) Study","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07714395","publication_url":"https://clinicaltrials.gov/study/NCT07714395","title":"Phase 1/2 Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-Tumor Activity of Elraglusib Oral Tablets in Adult Participants With Advanced Solid Tumors.","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Actuate Therapeutics Inc.","sponsor_slug":"actuate-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07829302","publication_url":"https://clinicaltrials.gov/study/NCT07829302","title":"A Phase 1/2, First-in-Human, Adaptive, Model-based, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of VV-14299 and VV-14300 (Adeno-associated Virus Vector-mediated Insulin and Glucokinase) in Adults With Long-Standing Type 1 Diabetes and Suboptimal Glycemic Control Using a Continuous Subcutaneous Insulin Infusion (CSII) Pump","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Kriya Therapeutics, Inc.","sponsor_slug":"kriya-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07493252","publication_url":"https://clinicaltrials.gov/study/NCT07493252","title":"Actify! An mHealth Mood Management Tool to Improve Population-Level Smoking Cessation","has_exemption":false,"start_date":"2026-11-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07820930","publication_url":"https://clinicaltrials.gov/study/NCT07820930","title":"A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation","has_exemption":false,"start_date":"2026-11-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07829757","publication_url":"https://clinicaltrials.gov/study/NCT07829757","title":"A Phase 4, Multicenter, Open-label, Safety and Antitumor Activity Study of Zolbetuximab Plus mFOLFOX6 or CAPOX as Firstline Treatment in Indian Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma","has_exemption":false,"start_date":"2026-11-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290530","publication_url":"https://clinicaltrials.gov/study/NCT07290530","title":"A 24-Month, Randomized, Double-Masked, Placebo-Controlled Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome","has_exemption":false,"start_date":"2026-12-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Nacuity Pharmaceuticals, Inc.","sponsor_slug":"nacuity-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07490067","publication_url":"https://clinicaltrials.gov/study/NCT07490067","title":"Personalizing Heart Failure Treatment With Genomics: A Clinical Trial to Understand the Mechanisms and Validate a Polygenic Risk Score for Beta-Blocker Response","has_exemption":false,"start_date":"2026-12-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07659743","publication_url":"https://clinicaltrials.gov/study/NCT07659743","title":"A Randomized, Double-blind, Sham-controlled, Parallel-group Trial Designed to Evaluate the Efficacy of BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)","has_exemption":false,"start_date":"2027-01-04","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05646563","publication_url":"https://clinicaltrials.gov/study/NCT05646563","title":"A Phase II, Open-Label Study of NM8074 in Soliris®-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)","has_exemption":false,"start_date":"2027-01-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"NovelMed Therapeutics","sponsor_slug":"novelmed-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07872709","publication_url":"https://clinicaltrials.gov/study/NCT07872709","title":"An Open-Label, Phase II Study Evaluating the Feasibility, Safety, and Efficacy of Oral Tetrahydrouridine-Decitabine in Patients With Advanced Myeloproliferative Neoplasms","has_exemption":false,"start_date":"2027-01-31","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"John Mascarenhas","sponsor_slug":"john-mascarenhas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07639684","publication_url":"https://clinicaltrials.gov/study/NCT07639684","title":"Metabolic Effects of Endoscopic Sleeve Gastroplasty in Obese Adults With Type 2 Diabetes: Evaluation of Glycemic Control, Insulin Use and Obesity Response","has_exemption":false,"start_date":"2027-04-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04539236","publication_url":"https://clinicaltrials.gov/study/NCT04539236","title":"A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients","has_exemption":false,"start_date":"2021-11-09","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"Mikkael Sekeres MD","sponsor_slug":"mikkael-sekeres-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05377177","publication_url":"https://clinicaltrials.gov/study/NCT05377177","title":"Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression (COMBAT-SI)","has_exemption":false,"start_date":"2022-09-02","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05985161","publication_url":"https://clinicaltrials.gov/study/NCT05985161","title":"A Multi-Center Phase II Study of Selinexor in Treating Recurrent or Refractory Wilms Tumor and Other Pediatric Solid Tumors","has_exemption":false,"start_date":"2023-08-01","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05659381","publication_url":"https://clinicaltrials.gov/study/NCT05659381","title":"GOG-3068: A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Cisplatin Versus no HIPEC at the Time of Optimal Interval Cytoreductive Surgery Followed by Niraparib Maintenance in Patients With Homologous Recombinant Deficient (HRD +) Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (Heated Ovarian Treatment Trial)","has_exemption":false,"start_date":"2024-03-08","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"GOG Foundation","sponsor_slug":"gog-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06819020","publication_url":"https://clinicaltrials.gov/study/NCT06819020","title":"Adaptive Deep Brain Stimulation to Improve Freezing of Gait in Parkinson's Disease Using Percept RC","has_exemption":false,"start_date":"2026-01-31","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"Doris Wang, MD, PhD","sponsor_slug":"doris-wang-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07579221","publication_url":"https://clinicaltrials.gov/study/NCT07579221","title":"Phase 1/2 Trial Of Navlimetostat With Pumitamig, A PD-L1/VEGF Bispecific Fusion Protein, In MTAP-Deficient Advanced Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-07-16","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07632820","publication_url":"https://clinicaltrials.gov/study/NCT07632820","title":"Ultrasound-guided Erector Spinae Plane (ESP) Block Versus Trigger Point Injection (TPI) for Chronic Thoracic Myofascial Pain: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-08-13","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06996652","publication_url":"https://clinicaltrials.gov/study/NCT06996652","title":"An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)","has_exemption":false,"start_date":"2026-08-17","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07603375","publication_url":"https://clinicaltrials.gov/study/NCT07603375","title":"A Single-arm Study of Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07694089","publication_url":"https://clinicaltrials.gov/study/NCT07694089","title":"A Randomized Trial of Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas","has_exemption":false,"start_date":"2026-10-01","completion_date":"2029-08-01","has_results":false,"results_due":false,"sponsor_name":"Akshitkumar MIstry","sponsor_slug":"akshitkumar-mistry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05450705","publication_url":"https://clinicaltrials.gov/study/NCT05450705","title":"A Phase 3 Open-Label Immunogenicity and Safety Study of 2-Dose Regimens of a 9vHPV Vaccine (V503) in Chinese Girls 9 Through 14 Years of Age With a Comparison to 3-Dose Regimen of V503 in Chinese Women 20 Through 26 Years of Age","has_exemption":false,"start_date":"2022-07-22","completion_date":"2029-08-03","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07772232","publication_url":"https://clinicaltrials.gov/study/NCT07772232","title":"Prospective Randomized Controlled Comparison of Holmium Laser Enucleation of the Prostate With Robotic Water Jet Ablation","has_exemption":false,"start_date":"2026-08-03","completion_date":"2029-08-03","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285460","publication_url":"https://clinicaltrials.gov/study/NCT07285460","title":"An Open-label, Parallel, Phase 3, Two-arm Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B With or Without Inhibitory Antibodies to Factors VIII or IX","has_exemption":false,"start_date":"2025-12-18","completion_date":"2029-08-04","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06550076","publication_url":"https://clinicaltrials.gov/study/NCT06550076","title":"A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis","has_exemption":false,"start_date":"2024-09-04","completion_date":"2029-08-05","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06997068","publication_url":"https://clinicaltrials.gov/study/NCT06997068","title":"MC240701 Decentralized Pilot Study of Triple Oral Metronomic Chemotherapy for Patients With Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population","has_exemption":false,"start_date":"2025-08-07","completion_date":"2029-08-05","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07759752","publication_url":"https://clinicaltrials.gov/study/NCT07759752","title":"Transurethral Thermodilatation Versus Prostatic Urethral Lift for Moderate-to-Severe BPH: A Randomised Controlled Non-Inferiority Trial","has_exemption":false,"start_date":"2026-08-06","completion_date":"2029-08-05","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04849871","publication_url":"https://clinicaltrials.gov/study/NCT04849871","title":"Evaluation of Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma - BreaStBRT","has_exemption":false,"start_date":"2021-08-12","completion_date":"2029-08-06","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284745","publication_url":"https://clinicaltrials.gov/study/NCT07284745","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder","has_exemption":false,"start_date":"2026-09-11","completion_date":"2029-08-06","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285798","publication_url":"https://clinicaltrials.gov/study/NCT07285798","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder","has_exemption":false,"start_date":"2026-10-02","completion_date":"2029-08-06","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06745323","publication_url":"https://clinicaltrials.gov/study/NCT06745323","title":"A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With Small Cell Lung Cancer (SCLC) (DeLLphi-309)","has_exemption":false,"start_date":"2025-02-26","completion_date":"2029-08-10","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07722312","publication_url":"https://clinicaltrials.gov/study/NCT07722312","title":"A Phase 1/2, Dose Optimization and Dose Expansion, Multicenter, Open-label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Menin Inhibitor S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Patients With Relapsed or Refractory Acute Myeloid Leukemia With NPM1c Mutation","has_exemption":false,"start_date":"2026-10-20","completion_date":"2029-08-11","has_results":false,"results_due":false,"sponsor_name":"Servier","sponsor_slug":"servier","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990529","publication_url":"https://clinicaltrials.gov/study/NCT06990529","title":"An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Leniolisib for Immune Dysregulation in Primary Immunodeficiency Disorders","has_exemption":false,"start_date":"2025-04-29","completion_date":"2029-08-12","has_results":false,"results_due":false,"sponsor_name":"Pharming Technologies B.V.","sponsor_slug":"pharming-technologies-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07065630","publication_url":"https://clinicaltrials.gov/study/NCT07065630","title":"A Phase II Study of Volrustomig, Paclitaxel, and Carboplatin Followed by Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer","has_exemption":false,"start_date":"2025-10-07","completion_date":"2029-08-13","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184944","publication_url":"https://clinicaltrials.gov/study/NCT07184944","title":"A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2026-01-22","completion_date":"2029-08-13","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06992427","publication_url":"https://clinicaltrials.gov/study/NCT06992427","title":"High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial","has_exemption":false,"start_date":"2025-06-05","completion_date":"2029-08-15","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07081646","publication_url":"https://clinicaltrials.gov/study/NCT07081646","title":"A Phase 1b/2 Study of AZD0120 (Also Known as GC012F), a Chimeric Antigen Receptor T Cell Therapy Targeting CD19 and B Cell Maturation Antigen in Participants With Relapsed or Refractory AL Amyloidosis.","has_exemption":false,"start_date":"2025-08-18","completion_date":"2029-08-15","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07412470","publication_url":"https://clinicaltrials.gov/study/NCT07412470","title":"A Seamless Phase 2/3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients","has_exemption":false,"start_date":"2026-03-13","completion_date":"2029-08-15","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07621809","publication_url":"https://clinicaltrials.gov/study/NCT07621809","title":"A Randomized, Double-blind, Placebo-controlled, 2-arm Multicenter Phase III Study to Assess the Efficacy and Safety of Ianalumab in Participants With Sjogren's Disease With High Symptom Burden (THALASSA)","has_exemption":false,"start_date":"2026-07-16","completion_date":"2029-08-15","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07431281","publication_url":"https://clinicaltrials.gov/study/NCT07431281","title":"A Phase III, Multicentre, Randomised Controlled Study of Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in First-Line Claudin18.2-Positive, HER2-Negative, Advanced/Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (CLARITY-Gastric 02)","has_exemption":false,"start_date":"2026-02-03","completion_date":"2029-08-16","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286149","publication_url":"https://clinicaltrials.gov/study/NCT07286149","title":"KEYMAKER-U01 Substudy 01F: A Phase 1b/2 Umbrella Study With Rolling Arms of Investigational Agents for Previously Treated Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With KRAS G12C Mutations","has_exemption":false,"start_date":"2026-04-30","completion_date":"2029-08-17","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07318610","publication_url":"https://clinicaltrials.gov/study/NCT07318610","title":"A Master Protocol for a Phase 3, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of REGN7508 and REGN9933, Monoclonal Antibodies Against Factor XI, in Participants With Recent Lower Extremity Revascularization for Symptomatic Peripheral Artery Disease (ROXI-PALISADE)","has_exemption":false,"start_date":"2026-07-10","completion_date":"2029-08-18","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07700979","publication_url":"https://clinicaltrials.gov/study/NCT07700979","title":"A Randomized, Double-blind, Multi-regional Phase 3 Study of Cadonilimab Combined With Chemotherapy Versus Chemotherapy in Combination With or Without Nivolumab for the First-line Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma","has_exemption":false,"start_date":"2026-09-24","completion_date":"2029-08-18","has_results":false,"results_due":false,"sponsor_name":"Akeso","sponsor_slug":"akeso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07441642","publication_url":"https://clinicaltrials.gov/study/NCT07441642","title":"A Randomized, Double Masked, Placebo-controlled, Multicenter, Dose-range Finding Study to Assess the Efficacy and Safety of FWY003 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration","has_exemption":false,"start_date":"2026-03-09","completion_date":"2029-08-21","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672251","publication_url":"https://clinicaltrials.gov/study/NCT05672251","title":"A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma","has_exemption":false,"start_date":"2024-01-02","completion_date":"2029-08-24","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06635148","publication_url":"https://clinicaltrials.gov/study/NCT06635148","title":"Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies","has_exemption":false,"start_date":"2024-09-19","completion_date":"2029-08-24","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03899155","publication_url":"https://clinicaltrials.gov/study/NCT03899155","title":"Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies","has_exemption":false,"start_date":"2019-08-09","completion_date":"2029-08-25","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07454382","publication_url":"https://clinicaltrials.gov/study/NCT07454382","title":"Phase 2 Trial of Elranatamab With Cyclophosphamide in Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2026-02-27","completion_date":"2029-08-27","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07551596","publication_url":"https://clinicaltrials.gov/study/NCT07551596","title":"A Phase 2 Study of Microsatellite Stable Colorectal Cancer (Stage 2 or 3) With Radiographic Occult Molecular Residual Disease Treated With Botensilimab (AGEN1181; Bot) Plus Balstilimab (AGEN2034, Bal) After Established Definitive Therapy (COMBAT Study)","has_exemption":false,"start_date":"2027-05-25","completion_date":"2029-08-28","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04365374","publication_url":"https://clinicaltrials.gov/study/NCT04365374","title":"A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (STaRT) With Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors.","has_exemption":false,"start_date":"2021-04-06","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"GT Medical Technologies, Inc.","sponsor_slug":"gt-medical-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05878717","publication_url":"https://clinicaltrials.gov/study/NCT05878717","title":"A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (SSC-ILD)","has_exemption":false,"start_date":"2023-09-13","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06088290","publication_url":"https://clinicaltrials.gov/study/NCT06088290","title":"Randomized, Controlled, Open-label, Phase III Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Patients With Metastatic Leiomyosarcoma","has_exemption":false,"start_date":"2023-09-21","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"PharmaMar","sponsor_slug":"pharmamar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06572384","publication_url":"https://clinicaltrials.gov/study/NCT06572384","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Belimumab Administered Subcutaneously in Adults With Interstitial Lung Disease (ILD) Associated With Connective Tissue Disease (CTD)","has_exemption":false,"start_date":"2024-09-11","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07242105","publication_url":"https://clinicaltrials.gov/study/NCT07242105","title":"Optimized Methods for Measuring Brain Excitability in Depression","has_exemption":false,"start_date":"2025-10-23","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06837480","publication_url":"https://clinicaltrials.gov/study/NCT06837480","title":"Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors With Chronic Lymphedema","has_exemption":false,"start_date":"2026-01-15","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104331","publication_url":"https://clinicaltrials.gov/study/NCT07104331","title":"SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma","has_exemption":false,"start_date":"2026-02-24","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"Sarcoma Alliance for Research through Collaboration","sponsor_slug":"sarcoma-alliance-for-research-through-collaboration","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05379153","publication_url":"https://clinicaltrials.gov/study/NCT05379153","title":"The Revitalize Trial: Reducing Vaginal Atrophy With Fractional CO2 Laser for Breast Cancer Survivors","has_exemption":false,"start_date":"2026-04-21","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07629167","publication_url":"https://clinicaltrials.gov/study/NCT07629167","title":"A Phase 2 Study of Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway","has_exemption":false,"start_date":"2026-08-30","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07808697","publication_url":"https://clinicaltrials.gov/study/NCT07808697","title":"A Phase 2, Randomized, Observer-Blind, Dose Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age","has_exemption":false,"start_date":"2026-09-01","completion_date":"2029-08-30","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03228667","publication_url":"https://clinicaltrials.gov/study/NCT03228667","title":"QUILT-3.055: A Phase IIb, Multicohort, Open-Label Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors","has_exemption":false,"start_date":"2018-12-11","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03737214","publication_url":"https://clinicaltrials.gov/study/NCT03737214","title":"A Multi-center, Open-label, Uncontrolled, Single-arm, Extension Study to Determine the Long-term Safety and Tolerability of Oral Lucerastat in Adult Subjects With Fabry Disease","has_exemption":false,"start_date":"2018-12-18","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Idorsia Pharmaceuticals Ltd.","sponsor_slug":"idorsia-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06450158","publication_url":"https://clinicaltrials.gov/study/NCT06450158","title":"Robot-assisted Hand Training to Induce Manual Functional Change and Cerebral Neural Plasticity in Children With Cerebral Palsy","has_exemption":false,"start_date":"2021-09-25","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Cook Children's Health Care System","sponsor_slug":"cook-childrens-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05071300","publication_url":"https://clinicaltrials.gov/study/NCT05071300","title":"An Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy","has_exemption":false,"start_date":"2022-01-04","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05307055","publication_url":"https://clinicaltrials.gov/study/NCT05307055","title":"Theta Burst Subthalamic Nucleus Deep Brain Stimulation for Cognitive and Motor Improvements in Parkinson's Disease","has_exemption":false,"start_date":"2022-01-11","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05667493","publication_url":"https://clinicaltrials.gov/study/NCT05667493","title":"An Open-Label Extension Study to Assess the Long-Term Safety of Eplontersen (ION-682884) in Patients With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)","has_exemption":false,"start_date":"2022-11-30","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05645107","publication_url":"https://clinicaltrials.gov/study/NCT05645107","title":"A Randomized, Multi-Center, Parallel, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® Plus Standard Medical Treatment Compared to Placebo Plus Standard Medical Treatment to Prevent Infections in Patients With Hypogammaglobulinemia and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-12-26","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05496998","publication_url":"https://clinicaltrials.gov/study/NCT05496998","title":"Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial","has_exemption":false,"start_date":"2023-02-07","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiovascular","sponsor_slug":"medtronic-cardiovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05777993","publication_url":"https://clinicaltrials.gov/study/NCT05777993","title":"A Rollover Study to Provide Continued Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study","has_exemption":false,"start_date":"2023-07-06","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Agios Pharmaceuticals, Inc.","sponsor_slug":"agios-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05838287","publication_url":"https://clinicaltrials.gov/study/NCT05838287","title":"Pioglitazone, Lipotoxicity, and Heart Failure With Preserved Ejection Fraction (HFpEF)","has_exemption":false,"start_date":"2023-07-10","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05832229","publication_url":"https://clinicaltrials.gov/study/NCT05832229","title":"Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study","has_exemption":false,"start_date":"2023-12-07","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06364280","publication_url":"https://clinicaltrials.gov/study/NCT06364280","title":"Pediatric Prehospital Airway Resuscitation Trial","has_exemption":false,"start_date":"2024-05-20","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06188585","publication_url":"https://clinicaltrials.gov/study/NCT06188585","title":"Randomized Controlled Multi-Center Non-Inferiority Trial of UI-EWD (Nexpowder™) vs. Conventional Treatment as First-Line Endoscopic Therapy for Patients With High-Risk Nonvariceal Upper Gastrointestinal Bleeding (TREET)","has_exemption":false,"start_date":"2024-06-21","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06219174","publication_url":"https://clinicaltrials.gov/study/NCT06219174","title":"Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC","has_exemption":false,"start_date":"2024-08-07","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05843253","publication_url":"https://clinicaltrials.gov/study/NCT05843253","title":"Phase 2 Study of Ribociclib-Containing Post-Radiotherapy Combinations in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma: Ribociclib and Everolimus for HGG/DIPG Which Harbor Alterations of the Cell Cycle and/or PI3K/mTOR Pathways AND Ribociclib and Temozolomide for DHG, H3G34-mutant","has_exemption":false,"start_date":"2024-08-22","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06553872","publication_url":"https://clinicaltrials.gov/study/NCT06553872","title":"A Phase 2, Open-Label, Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle Cell Lymphoma","has_exemption":false,"start_date":"2024-08-23","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492616","publication_url":"https://clinicaltrials.gov/study/NCT06492616","title":"Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase 3 Study","has_exemption":false,"start_date":"2024-09-27","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Stemline Therapeutics, Inc.","sponsor_slug":"stemline-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07050355","publication_url":"https://clinicaltrials.gov/study/NCT07050355","title":"Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking (RESTORATION)","has_exemption":false,"start_date":"2024-11-01","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06517212","publication_url":"https://clinicaltrials.gov/study/NCT06517212","title":"Adjuvant Tirzepatide Plus Standard of Care Endocrine Therapy in Patients With Obesity or Overweight Who Have Hormone Receptor-positive, HER2-negative, Node-positive Early Breast Cancer, With Molecular Residual Disease (MRD), as Determined by Circulating Tumor DNA (ctDNA)","has_exemption":false,"start_date":"2024-11-26","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06105164","publication_url":"https://clinicaltrials.gov/study/NCT06105164","title":"Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans","has_exemption":false,"start_date":"2024-12-05","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06517888","publication_url":"https://clinicaltrials.gov/study/NCT06517888","title":"A Phase 1/2 Trial of AAVAnc80-antiVEGF Gene Therapy in Individuals With Unilateral Vestibular Schwannoma","has_exemption":false,"start_date":"2025-01-17","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Akouos, Inc.","sponsor_slug":"akouos-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06788756","publication_url":"https://clinicaltrials.gov/study/NCT06788756","title":"A Pivotal Phase 2/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of L Annamycin for Injection in Combination With Cytarabine Injection Versus Placebo in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed Acute Myeloid Leukemia","has_exemption":false,"start_date":"2025-03-12","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Moleculin Biotech, Inc.","sponsor_slug":"moleculin-biotech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06956300","publication_url":"https://clinicaltrials.gov/study/NCT06956300","title":"Grit Against Cognitive Decline in Aging and Preclinical Alzheimer's Disease","has_exemption":false,"start_date":"2025-04-07","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827236","publication_url":"https://clinicaltrials.gov/study/NCT06827236","title":"A Phase I/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT323 in Combination With BNT327 in Participants With Advanced Breast Cancer","has_exemption":false,"start_date":"2025-04-23","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06811233","publication_url":"https://clinicaltrials.gov/study/NCT06811233","title":"Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study","has_exemption":false,"start_date":"2025-05-08","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06902558","publication_url":"https://clinicaltrials.gov/study/NCT06902558","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)","has_exemption":false,"start_date":"2025-06-09","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Calico Life Sciences LLC","sponsor_slug":"calico-life-sciences-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044635","publication_url":"https://clinicaltrials.gov/study/NCT07044635","title":"Radiation Therapy in Reduced Dose and Hypofractionated Schedule After Trans-Oral Robotic Surgery in Intermediate Risk HPV-Mediated Oropharyngeal Squamous Cell Carcinoma","has_exemption":false,"start_date":"2025-07-23","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06993675","publication_url":"https://clinicaltrials.gov/study/NCT06993675","title":"Improving MRD Negativity Rates in Newly Diagnosed Multiple Myeloma Patients: a Response-adaptive Approach of Consolidation With One or Two Bispecific T-cell Engagers Against GPRC5D or BCMA","has_exemption":false,"start_date":"2025-08-21","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Noffar Bar","sponsor_slug":"noffar-bar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06955169","publication_url":"https://clinicaltrials.gov/study/NCT06955169","title":"MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma","has_exemption":false,"start_date":"2025-08-24","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"RTOG Foundation, Inc.","sponsor_slug":"rtog-foundation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06866964","publication_url":"https://clinicaltrials.gov/study/NCT06866964","title":"A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy","has_exemption":false,"start_date":"2025-08-28","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06629259","publication_url":"https://clinicaltrials.gov/study/NCT06629259","title":"Guanfacine for Alcohol Use Disorder (AUD): a Telehealth Approach","has_exemption":false,"start_date":"2025-10-03","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212114","publication_url":"https://clinicaltrials.gov/study/NCT07212114","title":"A Randomized, Double-blind, Active Controlled, Single-center Study to Evaluate the Efficacy of EXPAREL vs. Bupivacaine HCl Administered as Combined Sciatic (in the Popliteal Fossa) and Saphenous (in the Adductor Canal) Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Total Ankle Arthroplasty","has_exemption":false,"start_date":"2025-11-17","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07166094","publication_url":"https://clinicaltrials.gov/study/NCT07166094","title":"A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Endometrial Cancer After Platinum-Based Chemotherapy and PD(L)-1 Therapy","has_exemption":false,"start_date":"2025-11-28","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222579","publication_url":"https://clinicaltrials.gov/study/NCT07222579","title":"A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)","has_exemption":false,"start_date":"2026-01-15","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223541","publication_url":"https://clinicaltrials.gov/study/NCT07223541","title":"A Randomized Phase II Trial of Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Oligo-Metastatic Clear Cell Renal Cell Carcinoma","has_exemption":false,"start_date":"2026-01-15","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625073","publication_url":"https://clinicaltrials.gov/study/NCT06625073","title":"Randomized Trial of Sodium-glucose Cotransporter 2 Inhibition in Heart Transplant Recipients","has_exemption":false,"start_date":"2026-01-20","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07201129","publication_url":"https://clinicaltrials.gov/study/NCT07201129","title":"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of Cenerimod in Adult Patients With Systemic Lupus Erythematosus and Active Lupus Nephritis in Combination With Background Therapy","has_exemption":false,"start_date":"2026-02-09","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07409272","publication_url":"https://clinicaltrials.gov/study/NCT07409272","title":"A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ASP3082 in Combination With mFOLFIRINOX or NALIRIFOX as First-line Treatment in Participants With KRAS G12D Mutated Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-02-17","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593977","publication_url":"https://clinicaltrials.gov/study/NCT06593977","title":"A Multicenter, Evaluator-Blinded, Randomized Evaluation of DYNAVISC in Pain Reduction Following Revision Surgery for Persistent or Recurrent Carpal Tunnel Syndrome","has_exemption":false,"start_date":"2026-03-26","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"FzioMed","sponsor_slug":"fziomed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07279558","publication_url":"https://clinicaltrials.gov/study/NCT07279558","title":"Effects of Full-spectrum Cannabidiol on Alcohol Consumption and Alcohol Use Disorder Phenotypes: Implications for Precision Medicine","has_exemption":false,"start_date":"2026-04-21","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07574593","publication_url":"https://clinicaltrials.gov/study/NCT07574593","title":"NORM-HF (NORM-guided Congestion Management in Heart Failure) Pivotal Study","has_exemption":false,"start_date":"2026-05-29","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Foundry Innovation & Research 1, Limited (FIRE1)","sponsor_slug":"foundry-innovation-research-1-limited-fire1","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06465290","publication_url":"https://clinicaltrials.gov/study/NCT06465290","title":"Promoting Neuroplastic Changes of Patients With TBI","has_exemption":false,"start_date":"2026-07-16","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07656415","publication_url":"https://clinicaltrials.gov/study/NCT07656415","title":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease","has_exemption":false,"start_date":"2026-07-21","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Agios Pharmaceuticals, Inc.","sponsor_slug":"agios-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07682662","publication_url":"https://clinicaltrials.gov/study/NCT07682662","title":"Evaluation of a Standardized Low-Dose Bolus Ketamine Pathway for Management of Pediatric Sickle Cell Patients Presenting to the Emergency Department With Pain","has_exemption":false,"start_date":"2026-08-01","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Mississippi Medical Center","sponsor_slug":"university-of-mississippi-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07795749","publication_url":"https://clinicaltrials.gov/study/NCT07795749","title":"Phase II Basket Trial of Intraperitoneal Paclitaxel Plus Systemic Therapy in Gastrointestinal Malignancies With Peritoneal Carcinomatosis (STOPGAP - B)","has_exemption":false,"start_date":"2026-08-04","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07794579","publication_url":"https://clinicaltrials.gov/study/NCT07794579","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Once-Daily Oral Orforglipron Compared With Placebo in Individuals With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity","has_exemption":false,"start_date":"2026-08-26","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212998","publication_url":"https://clinicaltrials.gov/study/NCT07212998","title":"Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Jason Sperry","sponsor_slug":"jason-sperry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07471139","publication_url":"https://clinicaltrials.gov/study/NCT07471139","title":"The SWITCH Trial: A Randomized Controlled Study of Apixaban Versus Vitamin K Antagonists in Patients With HeartMate 3 Left Ventricular Assist Devices","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07694986","publication_url":"https://clinicaltrials.gov/study/NCT07694986","title":"Phase 2 Trial With a Safety Run-in of Combinatorial Therapies With Intrathecal (IT) Dendritic Cell Vaccines (cDC1s) inHER+ (Combined With IT Trastuzumab) and HER2- (Combined With IT Nivolumab) Breast Cancer (BC) Leptomeningeal Disease (LMD)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07713459","publication_url":"https://clinicaltrials.gov/study/NCT07713459","title":"A Phase II Single Arm, Open Label Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Kure Cells, INC","sponsor_slug":"kure-cells-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07732634","publication_url":"https://clinicaltrials.gov/study/NCT07732634","title":"RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07750496","publication_url":"https://clinicaltrials.gov/study/NCT07750496","title":"Study Testing Outcomes After Planned Discontinuation of AntiSeizure Medication","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07503340","publication_url":"https://clinicaltrials.gov/study/NCT07503340","title":"An Open-label Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis","has_exemption":false,"start_date":"2026-10-30","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07836101","publication_url":"https://clinicaltrials.gov/study/NCT07836101","title":"Phase II Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Patients With Clinically Significant Immune Related Adverse Events (The IRIS Trial: Immune Checkpoint Inhibitor Rechallenge Involving Sarilumab)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07859683","publication_url":"https://clinicaltrials.gov/study/NCT07859683","title":"Transcranial Magnetic Stimulation to Augment Exposure and Response Prevention for Pediatric OCD","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Bradley Hospital","sponsor_slug":"bradley-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07501078","publication_url":"https://clinicaltrials.gov/study/NCT07501078","title":"Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation","has_exemption":false,"start_date":"2026-11-30","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Muhammad N Aslam, MD","sponsor_slug":"muhammad-n-aslam-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07680127","publication_url":"https://clinicaltrials.gov/study/NCT07680127","title":"Transcutaneous Auricular Vagal Nerve Stimulation for Treatment of Radiation Necrosis","has_exemption":false,"start_date":"2026-11-30","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05647811","publication_url":"https://clinicaltrials.gov/study/NCT05647811","title":"A Phase Ib, Open Label, Dose Escalation Study of NM8074 in Subjects With C3 Glomerulopathy (C3G)","has_exemption":false,"start_date":"2027-05-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"NovelMed Therapeutics","sponsor_slug":"novelmed-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05422469","publication_url":"https://clinicaltrials.gov/study/NCT05422469","title":"Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum","has_exemption":false,"start_date":"2027-08-31","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06940570","publication_url":"https://clinicaltrials.gov/study/NCT06940570","title":"A Randomized Single Center Trial to Determine the Efficacy of Methadone as a First Line Agent in the Reduction and Treatment of Pain in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2028-01-01","completion_date":"2029-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04770870","publication_url":"https://clinicaltrials.gov/study/NCT04770870","title":"Post Approval Study 2: Hintermann Series H3 Total Ankle Replacement System","has_exemption":false,"start_date":"2022-02-01","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"DT MedTech, LLC","sponsor_slug":"dt-medtech-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05963698","publication_url":"https://clinicaltrials.gov/study/NCT05963698","title":"The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)","has_exemption":false,"start_date":"2023-11-30","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"Hamilton Health Sciences Corporation","sponsor_slug":"hamilton-health-sciences-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06586021","publication_url":"https://clinicaltrials.gov/study/NCT06586021","title":"SEAL - Safety & Feasibility Evaluation of the Aortoseal™ for Seal and Fixation of Abdominal Aortic Aneurysms (AAA) Endovascular Grafts to the Aortic Wall\"","has_exemption":false,"start_date":"2024-02-06","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"Endoron Medical","sponsor_slug":"endoron-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06722391","publication_url":"https://clinicaltrials.gov/study/NCT06722391","title":"Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism","has_exemption":false,"start_date":"2024-08-19","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas, El Paso","sponsor_slug":"university-of-texas-el-paso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06525740","publication_url":"https://clinicaltrials.gov/study/NCT06525740","title":"Methadone Versus Intrathecal Hydromorphone for Postoperative Analgesia in Patients Undergoing Surgery for Gynecologic Malignancy Via Midline Laparotomy Receiving Liposomal Bupivacaine","has_exemption":false,"start_date":"2024-09-03","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06580041","publication_url":"https://clinicaltrials.gov/study/NCT06580041","title":"Precision Care for Major Depressive Disorder","has_exemption":false,"start_date":"2024-11-12","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06483061","publication_url":"https://clinicaltrials.gov/study/NCT06483061","title":"Ferumoxytol Enhanced Hippocampal Vascular Imaging in Epilepsy","has_exemption":false,"start_date":"2025-05-01","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Alberta","sponsor_slug":"university-of-alberta","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06645613","publication_url":"https://clinicaltrials.gov/study/NCT06645613","title":"Precision TMS With Integrated Visualization and Analysis of Real-time E-field and EEG Source Imaging","has_exemption":false,"start_date":"2026-03-01","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301268","publication_url":"https://clinicaltrials.gov/study/NCT07301268","title":"MC230719 Window Of Opportunity Study Of GI-102 In Patients With Recurrent High-Grade Glioblastoma","has_exemption":false,"start_date":"2026-08-03","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07515768","publication_url":"https://clinicaltrials.gov/study/NCT07515768","title":"Transcatheter Aortic Valve Implantation Without On-Site Cardiac Surgery in Poland: Protocol for a Multicenter Prospective Randomized Open-label Clinical Trial","has_exemption":false,"start_date":"2026-09-01","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"Medical University of Warsaw","sponsor_slug":"medical-university-of-warsaw","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07615075","publication_url":"https://clinicaltrials.gov/study/NCT07615075","title":"Randomized Double-Blind Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia","has_exemption":false,"start_date":"2026-09-01","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07658976","publication_url":"https://clinicaltrials.gov/study/NCT07658976","title":"Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy of HIV PrEP and STI PEP for Young Men","has_exemption":false,"start_date":"2026-09-01","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"HIV Prevention Trials Network","sponsor_slug":"hiv-prevention-trials-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07204080","publication_url":"https://clinicaltrials.gov/study/NCT07204080","title":"Phase II Clinical Trial Evaluating the Safety Efficacy of Fc-Modified Anti-CD154 mAB (TNX-1500) in Kidney Transplant Recipients","has_exemption":false,"start_date":"2026-11-01","completion_date":"2029-09-01","has_results":false,"results_due":false,"sponsor_name":"Ayman Al Jurdi, MD","sponsor_slug":"ayman-al-jurdi-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07761117","publication_url":"https://clinicaltrials.gov/study/NCT07761117","title":"A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Effect of Elecoglipron in Reducing Cardiovascular Outcomes in Participants With HFpEF and HFmrEF (Elevate-HF)","has_exemption":false,"start_date":"2026-08-24","completion_date":"2029-09-03","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07650916","publication_url":"https://clinicaltrials.gov/study/NCT07650916","title":"A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Cabotegravir Ultra Long-acting Plus Rilpivirine Ultra Long-acting or Cabotegravir Long-acting Plus Rilpivirine Long-acting in Adults and Adolescents With HIV Who Are Virologically Suppressed on ART","has_exemption":false,"start_date":"2026-06-25","completion_date":"2029-09-04","has_results":false,"results_due":false,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07818018","publication_url":"https://clinicaltrials.gov/study/NCT07818018","title":"A Phase 1b/II Study of Intratumoral CD40 Agonist 2141-V11 in Combination With Anti PD-1 and 5-Fluorouracil Therapy in Patients With Advanced Gastroesophageal Adenocarcinoma","has_exemption":false,"start_date":"2026-09-04","completion_date":"2029-09-04","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07723976","publication_url":"https://clinicaltrials.gov/study/NCT07723976","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Cannabidiol Oral Solution (CBD-OS, JZP926-OS) in Participants Aged 1 Year and Older With Developmental and Epileptic Encephalopathy (DEE)","has_exemption":false,"start_date":"2026-10-30","completion_date":"2029-09-04","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05541016","publication_url":"https://clinicaltrials.gov/study/NCT05541016","title":"DART 2.0: ctHPV-DNA Informed De-Escalated Adjuvant and Definitive Radiation Therapy","has_exemption":false,"start_date":"2023-03-20","completion_date":"2029-09-06","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07187375","publication_url":"https://clinicaltrials.gov/study/NCT07187375","title":"A Phase 2, Open-Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Crinecerfont in Pediatric Subjects 0 to <2 Years of Age With Congenital Adrenal Hyperplasia","has_exemption":false,"start_date":"2025-09-30","completion_date":"2029-09-06","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Switzerland GmbH","sponsor_slug":"neurocrine-switzerland-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07694427","publication_url":"https://clinicaltrials.gov/study/NCT07694427","title":"A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan With or Without Bevacizumab in Comparison to Active Observation With or Without Bevacizumab as Maintenance Treatment in Participants With Newly Diagnosed FIGO Stage III/IV Non-Homologous Recombination Deficient Ovarian Cancer","has_exemption":false,"start_date":"2026-10-09","completion_date":"2029-09-06","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04994717","publication_url":"https://clinicaltrials.gov/study/NCT04994717","title":"Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study)","has_exemption":false,"start_date":"2021-11-02","completion_date":"2029-09-07","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05827081","publication_url":"https://clinicaltrials.gov/study/NCT05827081","title":"A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-clinical Practice Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER)","has_exemption":false,"start_date":"2024-02-28","completion_date":"2029-09-07","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06875310","publication_url":"https://clinicaltrials.gov/study/NCT06875310","title":"A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)","has_exemption":false,"start_date":"2025-04-24","completion_date":"2029-09-07","has_results":false,"results_due":false,"sponsor_name":"Mirati Therapeutics Inc.","sponsor_slug":"mirati-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282613","publication_url":"https://clinicaltrials.gov/study/NCT07282613","title":"Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes","has_exemption":false,"start_date":"2026-08-04","completion_date":"2029-09-07","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07626411","publication_url":"https://clinicaltrials.gov/study/NCT07626411","title":"A Phase 3, Randomized, Multicenter, Double-blind Study to Assess Stroke and Systemic Embolism Prevention With REGN7508, a Monoclonal Antibody Against Factor XI, Versus Apixaban in Participants With Atrial Fibrillation (ROXI-EVEREST)","has_exemption":false,"start_date":"2026-08-10","completion_date":"2029-09-11","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07746687","publication_url":"https://clinicaltrials.gov/study/NCT07746687","title":"A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy and Safety of JNJ-95597528 for the Treatment of Adult Participants With Inadequately Controlled Moderate to Severe Asthma","has_exemption":false,"start_date":"2026-10-29","completion_date":"2029-09-11","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06469944","publication_url":"https://clinicaltrials.gov/study/NCT06469944","title":"A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma): Substudy 06C","has_exemption":false,"start_date":"2024-09-20","completion_date":"2029-09-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07700238","publication_url":"https://clinicaltrials.gov/study/NCT07700238","title":"A Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Adults With Previously Untreated Primary Immune Thrombocytopenia (ITP).","has_exemption":false,"start_date":"2026-08-21","completion_date":"2029-09-14","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07771439","publication_url":"https://clinicaltrials.gov/study/NCT07771439","title":"A Parallel Group, Phase 3, Randomized, Open-label, 2-arm Study to Demonstrate the Superiority of Belumosudil Versus Best Available Therapy (BAT) in Participants at Least 12 Years of Age With Chronic Graft Versus Host Disease (cGVHD) Refractory to or Recurrent After 2 to 5 Prior Lines of Systemic Therapy","has_exemption":false,"start_date":"2026-09-07","completion_date":"2029-09-14","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07675824","publication_url":"https://clinicaltrials.gov/study/NCT07675824","title":"A Phase 1/2 Study of REGN22530 in Participants With Primary Open Angle Glaucoma or Ocular Hypertension","has_exemption":false,"start_date":"2026-09-08","completion_date":"2029-09-14","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05144503","publication_url":"https://clinicaltrials.gov/study/NCT05144503","title":"A Safety and Performance Assessment of the SpherePVI™ Catheter and the Affera Mapping and Ablation System to Treat Paroxysmal Atrial Fibrillation","has_exemption":false,"start_date":"2021-07-22","completion_date":"2029-09-15","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiac Ablation Solutions","sponsor_slug":"medtronic-cardiac-ablation-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05115214","publication_url":"https://clinicaltrials.gov/study/NCT05115214","title":"A Safety and Performance Assessment of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation","has_exemption":false,"start_date":"2021-10-19","completion_date":"2029-09-15","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiac Ablation Solutions","sponsor_slug":"medtronic-cardiac-ablation-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07611357","publication_url":"https://clinicaltrials.gov/study/NCT07611357","title":"Total-Body [18F]F-AraG PET/CT Imaging to Quantify CNS and Systemic T Cell Involvement in Alzheimer's Disease","has_exemption":false,"start_date":"2026-05-16","completion_date":"2029-09-16","has_results":false,"results_due":false,"sponsor_name":"CellSight Technologies, Inc.","sponsor_slug":"cellsight-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05714202","publication_url":"https://clinicaltrials.gov/study/NCT05714202","title":"A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2023-03-23","completion_date":"2029-09-18","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04794101","publication_url":"https://clinicaltrials.gov/study/NCT04794101","title":"Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene","has_exemption":false,"start_date":"2020-12-04","completion_date":"2029-09-20","has_results":false,"results_due":false,"sponsor_name":"MeiraGTx Ocular UK Ltd","sponsor_slug":"meiragtx-ocular-uk-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07061938","publication_url":"https://clinicaltrials.gov/study/NCT07061938","title":"Phase 1b/2a Prospective, Open Label, Multicenter, Two-Arm Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With Immunoglobulin G4-Related Disease","has_exemption":false,"start_date":"2026-01-01","completion_date":"2029-09-20","has_results":false,"results_due":false,"sponsor_name":"Acepodia Biotech, Inc.","sponsor_slug":"acepodia-biotech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07747389","publication_url":"https://clinicaltrials.gov/study/NCT07747389","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Fixed Doses of Lumateperone Administered as Monotherapy in Participants With Major Depressive Disorder and an Open-label Long-term Extension Treatment With Lumateperone","has_exemption":false,"start_date":"2026-10-20","completion_date":"2029-09-20","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07836530","publication_url":"https://clinicaltrials.gov/study/NCT07836530","title":"A Randomized, Open-Label, Phase 3 Study to Investigate the Efficacy and Safety of BGB-B2033 Compared With Investigator Choice of Sorafenib or Lenvatinib in Patients With Hepatocellular Carcinoma That Progressed Upon Prior Systemic Treatment","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-09-21","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07743190","publication_url":"https://clinicaltrials.gov/study/NCT07743190","title":"NeoTILs: A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)","has_exemption":false,"start_date":"2027-01-01","completion_date":"2029-09-22","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07024394","publication_url":"https://clinicaltrials.gov/study/NCT07024394","title":"A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Ruvometinib Tablets (FCN-159 Tablets) in Pediatric Participants With Neurofibromatosis Type 1","has_exemption":false,"start_date":"2025-06-12","completion_date":"2029-09-23","has_results":false,"results_due":false,"sponsor_name":"Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.","sponsor_slug":"shanghai-fosun-pharmaceutical-industrial-development-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07607925","publication_url":"https://clinicaltrials.gov/study/NCT07607925","title":"A Phase 1/2 Open-label, Multi-center Study to Evaluate the Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)","has_exemption":false,"start_date":"2026-06-12","completion_date":"2029-09-24","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07862569","publication_url":"https://clinicaltrials.gov/study/NCT07862569","title":"A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Oral Doravirine/Islatravir (100 mg/0.25 mg) in Pediatric Participants With HIV-1 Infection Who Are Virologically Suppressed or Treatment-Naïve, Are Less Than 18 Years of Age, and Weigh Greater Than or Equal to 35 kg","has_exemption":false,"start_date":"2026-12-23","completion_date":"2029-09-24","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07590934","publication_url":"https://clinicaltrials.gov/study/NCT07590934","title":"A Phase Ib/II, Open-label, Multi-centre, Platform Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Multiple Anti-Cancer Agents in Metastatic Prostate Cancer","has_exemption":false,"start_date":"2026-06-03","completion_date":"2029-09-25","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07648264","publication_url":"https://clinicaltrials.gov/study/NCT07648264","title":"A Phase 3, Prospective, Open-label, Multicenter, Single-arm Study to Investigate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Subjects With Secondary Immune Deficiency Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies","has_exemption":false,"start_date":"2026-09-15","completion_date":"2029-09-27","has_results":false,"results_due":false,"sponsor_name":"CSL Behring","sponsor_slug":"csl-behring","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07839819","publication_url":"https://clinicaltrials.gov/study/NCT07839819","title":"Phase 1/2 Master Study to Assess the Safety and Efficacy of PM54 in Combination With Cytotoxic and Targeted Agents for the Treatment of Advanced Solid Tumors","has_exemption":false,"start_date":"2026-11-12","completion_date":"2029-09-27","has_results":false,"results_due":false,"sponsor_name":"PharmaMar","sponsor_slug":"pharmamar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04802603","publication_url":"https://clinicaltrials.gov/study/NCT04802603","title":"Dose-Escalated Spine SbRT (DESSRT) for Localized Metastasis to the Spinal Column","has_exemption":false,"start_date":"2021-03-14","completion_date":"2029-09-28","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02915198","publication_url":"https://clinicaltrials.gov/study/NCT02915198","title":"CSP #2002 - Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes (VA-IMPACT)","has_exemption":false,"start_date":"2023-04-03","completion_date":"2029-09-28","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02620852","publication_url":"https://clinicaltrials.gov/study/NCT02620852","title":"Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer (Wisdom Study)","has_exemption":false,"start_date":"2016-08-31","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03624660","publication_url":"https://clinicaltrials.gov/study/NCT03624660","title":"A Phase II Study of Dose-Escalated Proton-Based Radiation Therapy Delivered With a Simultaneous Integrated Boost (SIB) to Intraprostatic Tumors (IPT) Visible on Pretreatment Magnetic Resonance Image","has_exemption":false,"start_date":"2018-09-24","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03770572","publication_url":"https://clinicaltrials.gov/study/NCT03770572","title":"Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9","has_exemption":false,"start_date":"2018-11-13","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Neela Therapeutics","sponsor_slug":"neela-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04692181","publication_url":"https://clinicaltrials.gov/study/NCT04692181","title":"Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Recipients","has_exemption":false,"start_date":"2021-02-15","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Theriva Biologics, Inc.","sponsor_slug":"theriva-biologics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04892953","publication_url":"https://clinicaltrials.gov/study/NCT04892953","title":"Local Consolidative Therapy (LCT) and Durvalumab (MEDI4736) for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy (ENDURE)","has_exemption":false,"start_date":"2021-07-07","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05374590","publication_url":"https://clinicaltrials.gov/study/NCT05374590","title":"A Long-term, Single-Arm, Open-label, Multicenter Trial to Evaluate Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2022-08-18","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05445323","publication_url":"https://clinicaltrials.gov/study/NCT05445323","title":"A Phase 1/2 Study of the Safety and Efficacy of LX2006 Gene Therapy in Participants With Cardiomyopathy Associated With Friedreich's Ataxia","has_exemption":false,"start_date":"2022-08-24","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Lexeo Therapeutics","sponsor_slug":"lexeo-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05489887","publication_url":"https://clinicaltrials.gov/study/NCT05489887","title":"A Phase II Study of Naxitamab Added to Induction Therapy for Subjects With Newly Diagnosed High-Risk Neuroblastoma","has_exemption":false,"start_date":"2022-09-14","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Giselle Sholler","sponsor_slug":"giselle-sholler","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05405361","publication_url":"https://clinicaltrials.gov/study/NCT05405361","title":"A Long-term Extension of the ARGX-117-2002 Trial to Evaluate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy","has_exemption":false,"start_date":"2023-01-18","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05528133","publication_url":"https://clinicaltrials.gov/study/NCT05528133","title":"Phase II Study of Genomically Guided Radiation Dose Personalization in the Management of Triple Negative Breast Cancer","has_exemption":false,"start_date":"2023-01-25","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05633667","publication_url":"https://clinicaltrials.gov/study/NCT05633667","title":"A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung)","has_exemption":false,"start_date":"2023-03-16","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05891821","publication_url":"https://clinicaltrials.gov/study/NCT05891821","title":"Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)","has_exemption":false,"start_date":"2023-09-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Immune Oncology Research Institute","sponsor_slug":"immune-oncology-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06465745","publication_url":"https://clinicaltrials.gov/study/NCT06465745","title":"ATLAS (A Transseptal Left Atrial System for Treatment of Mitral Regurgitation) Pivotal Trial","has_exemption":false,"start_date":"2024-09-03","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"4C Medical Technologies, Inc.","sponsor_slug":"4c-medical-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06657859","publication_url":"https://clinicaltrials.gov/study/NCT06657859","title":"A Phase 2, Open-Label Extension Study to Assess the Safety and Efficacy of GLM101 Administered Intravenously to Participants With PMM2-CDG","has_exemption":false,"start_date":"2024-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Glycomine, Inc.","sponsor_slug":"glycomine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095205","publication_url":"https://clinicaltrials.gov/study/NCT07095205","title":"Central Cholinergic Dysfunction in Depression: PET Imaging of a Novel Treatment Target With [18F]VAT to Assess the Antidepressant Effect of Nicotine","has_exemption":false,"start_date":"2024-10-03","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06557512","publication_url":"https://clinicaltrials.gov/study/NCT06557512","title":"A Pilot Trial of Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma (SRS-AIM)","has_exemption":false,"start_date":"2024-12-13","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06526195","publication_url":"https://clinicaltrials.gov/study/NCT06526195","title":"Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure","has_exemption":false,"start_date":"2024-12-13","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06359041","publication_url":"https://clinicaltrials.gov/study/NCT06359041","title":"RESET-MG: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2024-12-17","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Cabaletta Bio","sponsor_slug":"cabaletta-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06406452","publication_url":"https://clinicaltrials.gov/study/NCT06406452","title":"A Multi-Center Trial to Assess the Safety and Effectiveness of a Bioresorbable Tracheobronchial Splint in Pediatric Subjects With Clinically Significant Tracheobronchomalacia","has_exemption":false,"start_date":"2025-01-07","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06493552","publication_url":"https://clinicaltrials.gov/study/NCT06493552","title":"A Modular, Open Label, Randomized Phase II/III Trial to Assess Efficacy of Combining sEphB4-HSA (EphrinB2 Inhibitor) With Immunotherapy Regimens in Patients With EphrinB2-High Solid Tumors","has_exemption":false,"start_date":"2025-03-15","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Vasgene Therapeutics, Inc","sponsor_slug":"vasgene-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06553885","publication_url":"https://clinicaltrials.gov/study/NCT06553885","title":"A Phase II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic Colorectal Cancer or Hepatocellular Carcinoma","has_exemption":false,"start_date":"2025-04-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06943872","publication_url":"https://clinicaltrials.gov/study/NCT06943872","title":"A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","has_exemption":false,"start_date":"2025-06-11","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07151677","publication_url":"https://clinicaltrials.gov/study/NCT07151677","title":"Pre-Frontal tDCS as a Novel Intervention to Reduce Effects of Post-Stroke Fatigue While Improving Language and Attention in Aphasia","has_exemption":false,"start_date":"2025-08-04","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Syracuse University","sponsor_slug":"syracuse-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07145255","publication_url":"https://clinicaltrials.gov/study/NCT07145255","title":"A Multicenter, Open-label Phase 1/2 Dose Finding, Safety, and Pharmacokinetic Study of MBRC-201, an Antibody-drug Conjugate, in Advanced Refractory Solid Tumors","has_exemption":false,"start_date":"2025-09-03","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"MBrace Therapeutics","sponsor_slug":"mbrace-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07091734","publication_url":"https://clinicaltrials.gov/study/NCT07091734","title":"Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024","has_exemption":false,"start_date":"2025-09-08","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07151248","publication_url":"https://clinicaltrials.gov/study/NCT07151248","title":"ELECTRIG: Evaluating Effects of Cranial Electrical Stimulation Therapy With Responsive Imaging in Gulf War Illness Pain and Comorbid Symptoms","has_exemption":false,"start_date":"2025-09-26","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07198529","publication_url":"https://clinicaltrials.gov/study/NCT07198529","title":"Optical Coherence Tomography for Stent Optimization and Its Impact on Short-Duration Dual Antiplatelet Therapy: A Single-Center, Prospective, Exploratory Study","has_exemption":false,"start_date":"2025-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Korea University Guro Hospital","sponsor_slug":"korea-university-guro-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06933706","publication_url":"https://clinicaltrials.gov/study/NCT06933706","title":"Losartan to Improve Outcomes After Multi-ligament Knee Injury","has_exemption":false,"start_date":"2025-10-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07178145","publication_url":"https://clinicaltrials.gov/study/NCT07178145","title":"MRI of Epicardial Adipose Tissue Composition: Development of Methods and Application to Heart Failure With Preserved Ejection Fraction","has_exemption":false,"start_date":"2025-11-20","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284784","publication_url":"https://clinicaltrials.gov/study/NCT07284784","title":"An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Parkinson's Disease","has_exemption":false,"start_date":"2026-01-09","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Annovis Bio Inc.","sponsor_slug":"annovis-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07230288","publication_url":"https://clinicaltrials.gov/study/NCT07230288","title":"A Phase 2a Multicenter Platform Study of Investigational Products for the Treatment of Adult Subjects With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2026-01-23","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06231563","publication_url":"https://clinicaltrials.gov/study/NCT06231563","title":"Examining Ketamine Effects on Depression, Neuroplasticity, and Inflammation in Veterans With Parkinson's Disease","has_exemption":false,"start_date":"2026-03-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219459","publication_url":"https://clinicaltrials.gov/study/NCT07219459","title":"A Phase 2b, Randomized, Blinded Trial Investigating the Efficacy and Safety of Visugromab in Combination With Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Participants With Unresectable or Metastatic Hepatocellular Carcinoma and Compensated Liver Function (Child-Pugh A) After Failure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound (GDFATHER HCC-01)","has_exemption":false,"start_date":"2026-03-19","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"CatalYm GmbH","sponsor_slug":"catalym-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07563738","publication_url":"https://clinicaltrials.gov/study/NCT07563738","title":"A 2-part Phase 1/2 Open-label Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ODM-212 in Combination With Anti-cancer Therapy in Participants With Advanced Solid Tumours","has_exemption":false,"start_date":"2026-03-27","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Orion Corporation, Orion Pharma","sponsor_slug":"orion-corporation-orion-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05842174","publication_url":"https://clinicaltrials.gov/study/NCT05842174","title":"Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma Through Image-guided Locoregional Therapy","has_exemption":false,"start_date":"2026-04-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06451757","publication_url":"https://clinicaltrials.gov/study/NCT06451757","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group, Pivotal Trial to Assess the Efficacy and Safety of Sonlicromanol in Adult Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Variant","has_exemption":false,"start_date":"2026-04-14","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Khondrion BV","sponsor_slug":"khondrion-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07569042","publication_url":"https://clinicaltrials.gov/study/NCT07569042","title":"A Rollover Study to Evaluate the Long-Term Safety and Efficacy of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma Who Completed Study NBM-BMX-003 (the Parent Study)","has_exemption":false,"start_date":"2026-04-20","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Novelwise Pharmaceutical Corporation","sponsor_slug":"novelwise-pharmaceutical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07602582","publication_url":"https://clinicaltrials.gov/study/NCT07602582","title":"An Annual Dosing Study of Donanemab in Participants Who Completed Donanemab Study AACM","has_exemption":false,"start_date":"2026-05-22","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07629960","publication_url":"https://clinicaltrials.gov/study/NCT07629960","title":"A Phase 1/2, Open-Label, Dose-Escalation, Dose-Enrichment, and Dose-Expansion Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of BLU-924 (SAR449336) as Monotherapy and Combination Therapy in Participants With Advanced Pancreatic Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer Harboring KRAS Mutations","has_exemption":false,"start_date":"2026-06-04","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Blueprint Medicines Corporation","sponsor_slug":"blueprint-medicines-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07605364","publication_url":"https://clinicaltrials.gov/study/NCT07605364","title":"Mycophenolate Mofetil to Overcome Glioblastoma Resistance to Radiotherapy and Temozolomide","has_exemption":false,"start_date":"2026-06-10","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07531251","publication_url":"https://clinicaltrials.gov/study/NCT07531251","title":"Phase 3b/4, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Daily Subcutaneous Injections of Elamipretide in Patients With Genetically Confirmed Barth Syndrome","has_exemption":false,"start_date":"2026-07-02","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Stealth BioTherapeutics Inc.","sponsor_slug":"stealth-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104916","publication_url":"https://clinicaltrials.gov/study/NCT07104916","title":"A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Anthony P King","sponsor_slug":"anthony-p-king","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07783412","publication_url":"https://clinicaltrials.gov/study/NCT07783412","title":"Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum","has_exemption":false,"start_date":"2026-09-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277738","publication_url":"https://clinicaltrials.gov/study/NCT07277738","title":"Precision Supplemental Imaging in Women With Dense Breasts (PSID Trial)","has_exemption":false,"start_date":"2026-09-09","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07798427","publication_url":"https://clinicaltrials.gov/study/NCT07798427","title":"A Prospective Randomized Controlled Study Comparing Ultrasound-Guided Peripheral Vascular Access With Standard Landmark/Palpation-Guided Access for Improving First-Attempt Cannulation Success","has_exemption":false,"start_date":"2026-09-15","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Truway Health, Inc.","sponsor_slug":"truway-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07778498","publication_url":"https://clinicaltrials.gov/study/NCT07778498","title":"A Phase I/II, First-in-Human, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Preliminary Efficacy, and Immunogenicity of TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.","has_exemption":false,"start_date":"2026-09-29","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Phrontline Biopharma","sponsor_slug":"phrontline-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282821","publication_url":"https://clinicaltrials.gov/study/NCT07282821","title":"Bempedoic Acid Therapy for Polycystic Kidney Disease (BEAT-PKD) Randomized Clinical Trial","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Kenneth Hallows","sponsor_slug":"kenneth-hallows","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526948","publication_url":"https://clinicaltrials.gov/study/NCT07526948","title":"Vaginal Estradiol Versus Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms, Dysbiosis and Markers of Latency Reversal in Menopausal Women Living With HIV","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07569965","publication_url":"https://clinicaltrials.gov/study/NCT07569965","title":"Phase II Multicenter Trial of MB-CART2019.1 (Zamtocabtagene Autoleucel) Therapy as Frontline Consolidation for High-Risk Mantle Cell Lymphoma","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Miltenyi Biomedicine GmbH","sponsor_slug":"miltenyi-biomedicine-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07687485","publication_url":"https://clinicaltrials.gov/study/NCT07687485","title":"Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Laplace Interventional, Inc","sponsor_slug":"laplace-interventional-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07700043","publication_url":"https://clinicaltrials.gov/study/NCT07700043","title":"Noise Reduction With Hearing Aids","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07722741","publication_url":"https://clinicaltrials.gov/study/NCT07722741","title":"IMPACT31: A Randomized Open-label, Multi-center, Phase II Adjuvant Study of a Personalized Neoantigen DNA Vaccine (GNOS-PV02) and Plasmid Encoded IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Geneos Therapeutics","sponsor_slug":"geneos-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07767825","publication_url":"https://clinicaltrials.gov/study/NCT07767825","title":"Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Congenital Diaphragmatic Hernia (CDH)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07779642","publication_url":"https://clinicaltrials.gov/study/NCT07779642","title":"Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07808151","publication_url":"https://clinicaltrials.gov/study/NCT07808151","title":"A Phase 2, Open-Label, Multicenter, Randomized Trial Evaluating the Efficacy and Safety of Different Schedules of Neoadjuvant Pembrolizumab and Porustobart in Patients With Resectable pMMR/MSS Colon Cancer","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Solstice Oncology, Inc.","sponsor_slug":"solstice-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07820917","publication_url":"https://clinicaltrials.gov/study/NCT07820917","title":"COMFORT: Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07831824","publication_url":"https://clinicaltrials.gov/study/NCT07831824","title":"A Prospective Phase 2/3, Multicenter, Open Label Study of [68Ga]- LNTH2401 PET/CT Imaging in Participants With Prostate Cancer: Phase 2 Dose Optimization in Either Newly Diagnosed or Biochemically Recurrent Prostate Cancer and Phase 3 Diagnostic Performance in Participants Who Are Newly Diagnosed and Have at Least High Risk or Suspected Metastatic Disease and Planning to Undergo Radical Prostatectomy Plus Pelvic Lymph Node Dissection (SPARROW)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Lantheus Medical Imaging","sponsor_slug":"lantheus-medical-imaging","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07864480","publication_url":"https://clinicaltrials.gov/study/NCT07864480","title":"Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP.","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Southeast Retina Center, Georgia","sponsor_slug":"southeast-retina-center-georgia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07864792","publication_url":"https://clinicaltrials.gov/study/NCT07864792","title":"A Randomized, Sham Controlled, Double Blinded, Crossover Mechanistic Trial of the Impact of Transcranial Direct Current to the Left Dorsolateral Prefrontal Cortex on Gait in Older Breast Cancer Survivor's Post-Taxane Chemotherapy","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07739537","publication_url":"https://clinicaltrials.gov/study/NCT07739537","title":"Polygenic Assessment and Testing of Heterogeneity and Subtypes in Type 2 Diabetes (PATHS-T2D): A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses","has_exemption":false,"start_date":"2026-10-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07706166","publication_url":"https://clinicaltrials.gov/study/NCT07706166","title":"An Interventional Study of Letermovir for Primary Prophylaxis of Cytomegalovirus Infection in Moderate Risk (R+) Abdominal Solid Organ Transplant Recipients","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07743541","publication_url":"https://clinicaltrials.gov/study/NCT07743541","title":"A Multicenter Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of the NaPi2B Antibody-Drug Conjugate TUB-040 in Patients With Recurrent or Progressive Uterine Endometrial Cancer After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitor Therapy","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660225","publication_url":"https://clinicaltrials.gov/study/NCT06660225","title":"Towards Closed Loop Deep Brain Stimulation for Treatment of Refractory Obsessive-Compulsive Disorder","has_exemption":false,"start_date":"2026-11-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Nader Pouratian","sponsor_slug":"nader-pouratian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07793578","publication_url":"https://clinicaltrials.gov/study/NCT07793578","title":"A Phase Ib/Phase II Trial With Capivasertib Plus Immunotherapy in Bladder Cancer","has_exemption":false,"start_date":"2027-01-01","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07170540","publication_url":"https://clinicaltrials.gov/study/NCT07170540","title":"Cashew Allergy Study in Children: Assessing Desensitization, Efficacy, and Safety (CASCADES Study)","has_exemption":false,"start_date":"2027-03-31","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07557134","publication_url":"https://clinicaltrials.gov/study/NCT07557134","title":"A Multi-center, Randomized, No Treatment, Concurrent Controlled Study of E-CEL UVEC CELLS for the Treatment of Perianal Fistula","has_exemption":false,"start_date":"2027-05-31","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Angiocrine Bioscience","sponsor_slug":"angiocrine-bioscience","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07437963","publication_url":"https://clinicaltrials.gov/study/NCT07437963","title":"Phase 1/2 Study of Dinutuximab/Cyclophosphamide/Topotecan/Sargramostim (GM-CSF) With or Without Iberdomide in Children With Relapsed, Refractory, or Progressive Neuroblastoma Following Prior Chemoimmunotherapy","has_exemption":false,"start_date":"2027-06-25","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07867210","publication_url":"https://clinicaltrials.gov/study/NCT07867210","title":"Memantine Targeting Neurovascular Dysfunction After Mild and Moderate Traumatic Brain Injury-A Randomized Feasibility Trial (MEND)","has_exemption":false,"start_date":"2027-06-30","completion_date":"2029-09-30","has_results":false,"results_due":false,"sponsor_name":"Nova Scotia Health Authority","sponsor_slug":"nova-scotia-health-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06465706","publication_url":"https://clinicaltrials.gov/study/NCT06465706","title":"A Prospective, Multicenter, Randomized Controlled Trial Assessing the Safety and Efficacy of the LAmbre™ Plus Left Atrial Appendage Closure System to REDUCE the Risk of Thromboembolism in Patients With Non-Valvular Atrial Fibrillation","has_exemption":false,"start_date":"2024-09-01","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"Kansas City Heart Rhythm Research Foundation","sponsor_slug":"kansas-city-heart-rhythm-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06306638","publication_url":"https://clinicaltrials.gov/study/NCT06306638","title":"A Phase I/II Study of Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients With Inoperable Malignant Central Airway Obstruction","has_exemption":false,"start_date":"2024-10-01","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05956821","publication_url":"https://clinicaltrials.gov/study/NCT05956821","title":"Phase I/II Trial of Repeat Dosing of Super-Selective Intraarterial Infusion of Erbitux (Cetuximab) and Avastin (Bevacizumab) for Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age","has_exemption":false,"start_date":"2025-06-19","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07246863","publication_url":"https://clinicaltrials.gov/study/NCT07246863","title":"Ph 2, Randomized, Blinded, Placebo-Controlled Trial Investigating the Efficacy and Safety of Visugromab and Nivolumab With or Without Docetaxel Versus Docetaxel in 2L Treatment of Participants With Metastatic NSCLC (GDFATHER-NSCLC-02)","has_exemption":false,"start_date":"2025-10-07","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"CatalYm GmbH","sponsor_slug":"catalym-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07128199","publication_url":"https://clinicaltrials.gov/study/NCT07128199","title":"A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Versus Placebo in Early Stage NSCLC Patients With Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)","has_exemption":false,"start_date":"2025-12-22","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"Taiho Oncology, Inc.","sponsor_slug":"taiho-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07593859","publication_url":"https://clinicaltrials.gov/study/NCT07593859","title":"Overcoming the Barriers to Effective Transcranial Temporal Interference Stimulation in Humans","has_exemption":false,"start_date":"2026-02-01","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"Northeastern University","sponsor_slug":"northeastern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07283705","publication_url":"https://clinicaltrials.gov/study/NCT07283705","title":"A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer","has_exemption":false,"start_date":"2026-04-09","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05935761","publication_url":"https://clinicaltrials.gov/study/NCT05935761","title":"Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial","has_exemption":false,"start_date":"2026-12-01","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06093425","publication_url":"https://clinicaltrials.gov/study/NCT06093425","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating Combination of TST001, Pembrolizumab and Chemotherapy as First-Line Treatment in Subjects With Claudin18.2 Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma","has_exemption":false,"start_date":"2027-06-30","completion_date":"2029-10-01","has_results":false,"results_due":false,"sponsor_name":"Transcenta Therapeutics (Hangzhou) Co., Ltd.","sponsor_slug":"transcenta-therapeutics-hangzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04871607","publication_url":"https://clinicaltrials.gov/study/NCT04871607","title":"A Phase 2 Trial of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy (aTac-BEAM) Conditioning for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients With Primary Refractory or Relapsed Hodgkin Lymphoma","has_exemption":false,"start_date":"2021-11-02","completion_date":"2029-10-02","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07115043","publication_url":"https://clinicaltrials.gov/study/NCT07115043","title":"A Phase I/II Open-label Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD6750, a CD8 Guided IL-2 Agent Alone and in Combination With Other Anti-cancer Agents in Participants With Select Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2025-07-29","completion_date":"2029-10-02","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06859099","publication_url":"https://clinicaltrials.gov/study/NCT06859099","title":"Long-term Extension Study to Evaluate the Safety and Efficacy of Riliprubart (SAR445088) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","has_exemption":false,"start_date":"2025-04-01","completion_date":"2029-10-03","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07867938","publication_url":"https://clinicaltrials.gov/study/NCT07867938","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Active Pulmonary Sarcoidosis","has_exemption":false,"start_date":"2026-11-06","completion_date":"2029-10-05","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06848088","publication_url":"https://clinicaltrials.gov/study/NCT06848088","title":"Extended Follow-up of Patients With Melanoma Treated With Fianlimab Plus Cemiplimab in Expansion Cohorts From Study R3767-ONC-1613","has_exemption":false,"start_date":"2025-04-14","completion_date":"2029-10-10","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null}]}